Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
48.86
-0.13 (-0.27%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bristol-Myers Squibb
< Previous
1
2
3
4
5
6
7
8
9
...
40
41
Next >
Stock Market Correction Intensifies; Google, Meta, Microsoft, Amazon Are Big Earnings Movers: Weekly Review
October 27, 2023
Microsoft, Google, Amazon and Meta led big earnings.
Via
Investor's Business Daily
Bristol Myers Squibb (BMY) Q3 2023 Earnings Call Transcript
October 26, 2023
BMY earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
US Stocks Mixed; Bristol Myers Posts Upbeat Earnings
October 26, 2023
U.S. stocks traded mixed this morning, following the release of several economic reports. Following the market opening Thursday, the Dow traded up 0.10% to 33,069.66 while the NASDAQ fell 0.24% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why LianBio Stock Is Skyrocketing Today
October 24, 2023
Investors are loving LianBio's new deal with Bristol Myers Squibb.
Via
The Motley Fool
What 12 Analyst Ratings Have To Say About Bristol-Myers Squibb
October 20, 2023
Via
Benzinga
3 Things About Bristol Myers Squibb That Smart Investors Know
October 19, 2023
The stock is down this year, but will its struggles fade into the rearview mirror?
Via
The Motley Fool
2 High-Yield Dividend Stocks to Buy Now
October 18, 2023
These two blue-chip stocks sport generous yields.
Via
The Motley Fool
Bristol Myers Squibb's Revlimid Sales Plunge 41%, but Opdivo and Eliquis Boost Q3, Stock Dips
October 26, 2023
Bristol Myers Squibb & Co (NYSE: BMY) said that its Q3 revenues of $10.966 billion declined 2% Y/Y, or 3% when adjusted for foreign exchange, due to lower sales of Revlimid, partially offset by in-line...
Via
Benzinga
Bristol Myers Skids 5% After Pushing Back A Key Sales Milestone By A Year
October 26, 2023
The company expects its new drugs to reach $10 billion in sales by 2026.
Via
Investor's Business Daily
Nasdaq Futures Plunge As Meta Warns Of Q4 Softness: GDP Data, Amazon Earnings On Investors' Radar Amid Market Mayhem
October 26, 2023
Stock futures are plunging after the mega-cap tech names haven't turned in the strong results that the markets had factored in.
Via
Benzinga
2 Absurdly Cheap Healthcare Stocks to Buy and Hold for Decades
October 26, 2023
You won't have to worry about paying a premium for either one of these stocks -- and they both pay a solid dividend.
Via
The Motley Fool
Meta, Amazon And 3 Stocks To Watch Heading Into Thursday
October 26, 2023
With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Fear Continues To Grip Markets As S&P 500 Settles Below 4,200
October 26, 2023
The CNN Money Fear and Greed index showed growth easing in the overall fear level, remaining in the "Fear" zone on Wednesday. U.S. stocks closed lower on Wednesday, with the S&P 500 closing the session...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
META Up +4% On +23% Revenue Growth; IBM And NOW Also Beat
October 25, 2023
Markets sagged throughout the course of today’s trading session after starting mixed, with the Dow basking in Microsoft’s stellar previous-afternoon’s earnings report.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
This Artificial Intelligence (AI) Stock Is Powering the Biotech Revolution: Should You Invest?
October 25, 2023
There's more to the AI boom than Microsoft and ChatGPT.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Is LianBio (LIAN) Stock Up 130% Today?
October 24, 2023
With LianBio inking a key exclusive licensing agreement with Bristol-Myers Squibb, LIAN stock is jumping up on the credibility implications.
Via
InvestorPlace
Why LianBio Stock Is Ripping Higher Today
October 24, 2023
LianBio (NASDAQ: LIAN) shares are trading higher Tuesday after the company announced an agreement with Bristol Myers Squibb (NYSE: BMY) to purchase LianBio's exclusive rights to develop and...
Via
Benzinga
'Never Buy A Drug Stock Just For The Yield': Jim Cramer On This Big Pharma Company
October 24, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended selling Petróleo Brasileiro S.A. - Petrobras (NYSE: PBR).
Via
Benzinga
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
October 21, 2023
The venerable pharmaceutical companies' shares have slumped this year.
Via
The Motley Fool
7 Healthcare Stocks That Can Cure a Lackluster Portfolio
October 19, 2023
Take a position in these companies' stocks to achieve long-term gains and give a jolt to your investment portfolio.
Via
InvestorPlace
Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market?
October 23, 2023
Factset data indicates that out of the 17% of the S&P 500 companies that have reported so far, 73% have reported positive EPS surprises.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Investor Risk Sentiment Wavers Amid War, Interest Rate Concerns; Tesla Earnings Disappoint: The Week In The Markets
October 20, 2023
In the week ahead, earnings season moves into full swing with reports from companies like Microsoft, Alphabet, Meta Platforms and Amazon.
Via
Benzinga
Opdivo's Subcutaneous Formulation Shows Promise in Advanced Kidney Cancer: Bristol Myers Squibb's Latest Findings
October 19, 2023
Bristol Myers Squibb Co (NYSE: BMY) released topline data from the Phase 3 CheckMate -67T noninferiority trial of a subcutaneous Opdivo (nivolumab) compared to intravenous (IV) Opdivo for advanced or...
Via
Benzinga
Could Bristol Myers Squibb Stock Help You Become a Millionaire?
October 19, 2023
Bristol Myers has been investing in growth, but will it be enough to get investors bullish on its struggling stock?
Via
The Motley Fool
Bristol Myers Squibb Highlights Opdivo Regime Data In Lung Cancer Settings
October 18, 2023
Bristol Myers Squibb & Co (NYSE: BMY) announced the first disclosure of data from the Phase 3 CheckMate -77T trial of the perioperative regimen of neoadjuvant Opdivo (nivolumab) with chemotherapy...
Via
Benzinga
2 Biotech Stocks That Could Make You Richer
October 17, 2023
These two well-known drugmakers still have some growth fuel in their seemingly empty tanks.
Via
The Motley Fool
FDA Approves Merck's Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication
October 17, 2023
The FDA approved Merck & Co Inc's (NYSE: MRK) Keytruda for resectable (tumors ≥4 centimeters [cm] or node-positive) non-small cell lung cancer (NSCLC) in combination with platinum-containing...
Via
Benzinga
Exposures
Product Safety
Why Is Alzheimer's Player Prothena Stock Trading Higher Today?
October 16, 2023
Prothena Corporation plc (NASDAQ: PRTA) is reportedly talking to advisors, potentially preparing for a sale.
Via
Benzinga
FDA OKs Pfizer's New Bowel Disease Drug, Analysts Predict Peak Sales Of $3B A Year
October 13, 2023
The Food and Drug Administration (FDA) approved Pfizer Inc's (NYSE: PFE) Velsipity (etrasimod), an oral, once-daily, selective sphingosine-1-phosphate (S1P) receptor modulator for adults with...
Via
Benzinga
Exposures
Product Safety
3 Healthcare Stocks To Make You The Millionaire Next Door: October Edition
October 13, 2023
These are the healthcare stocks to buy as they represent companies investing in research and development for growth and value creation.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
40
41
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.